324
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Endocrine factors, memory and perceptual capacities and aging in Asian men

&
Pages 77-83 | Received 03 Nov 2014, Accepted 18 Jan 2015, Published online: 18 Feb 2015

Abstract

Background: This cross-sectional study examined the associations of hormones and age with short-term memory and perceptual capacity in 472 healthy Asian men.

Methods: The symbol digit and digit span tests from the Swedish Performance Evaluation System were used to assess perceptual capacity and memory. Linear regression analyses with the stepwise method were carried out with the SPSS 21.0 package.

Results: Age was associated with lower dehydorepiandrosterone sulphate (DHEA/S), insulin growth factor-1 (IGF-1), thyroxine (T4), testosterone (T), bioavailable T (BioT) and error rate (Err) but higher glucose (GLU), sex hormone binding globulin (SHBG), estradiol (E2) and retention time (RT). High GLU was associated with higher error rate, longer RT of the perceptual capacity domain and shorter digit span (DSpan) of the short-term memory domain. Higher insulin-like growth factor binding protein-3 (BP3) was associated with longer DSpan. High cortisol (Cor) was associated with higher Err, while high DHEA/S was associated with shorter RT. All other hormones from the adrenal, somatotrophic and gonadal were not significantly associated with cognition.

Conclusion: The findings suggest (1) a role for tighter control of blood glucose levels in cognitive decline with aging in men, (2) different hormones may be related to different parameters of cognition and “cognition” is not a unitary phenomenon and (3) further investigation of the potential for exogenous DHEA/S to slow cognitive decline in aging, especially as it relates to reaction time.

Introduction

Aging is associated with changes in the functionality of various health compartments, including that of metabolic, cardiovascular, cognitive and endocrine compartments [Citation1–6]. In addition, the effects of aging occur in an inter-compartmental manner, where changes in one may affect others [Citation7,Citation8]. Evidence is beginning to accumulate which suggests that age-related changes in endocrine activities may be related to cognitive decline in man [Citation9]. However, a direct relationship between cognitive and endocrine changes has been difficult to prove. The difficulty may, in part, be due to the complexity of human cognition and the lack of accurate and reliable tools to measure the functional capacity of the different cognitive domains. Furthermore, it has been shown that cognition is affected by many factors including lifestyle, biochemical, social, environmental, genetic and hormonal factors [Citation8,Citation10,Citation11]. Amidst the many confounding factors, the challenge to tease out the individual factors having independent association with cognition is considerable. It is unclear whether age-related changes in the various endocrine axes are associated with cognition.

The gonadal, adrenal, somatotrophic and thyroid axes may have roles in the establishment and modulation of human behavior and cognition [Citation9]. However, the associations of these endocrine axes with cognition and their potential effects on the aging brain remain uncertain [Citation9]. Androgens were noted to be associated with visuospatial functions in elderly men on testosterone therapy and in men with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) [Citation12–15], but others have shown otherwise [Citation16–18]. The conflicting results could be related to the ages of the men, the endogenous levels of testosterone present and the cognitive function tests employed.

The adrenals secrete large amounts of dehydorepiandrosterone (DHEA) and dehydorepiandrosterone sulphate (DHEA/S) and cortisol (Cor). With aging, there is a progressive and continuous decline of DHEA/S levels [Citation19]. On the other hand, Cor levels show a slight parallel linear increase with aging or remain largely unchanged [Citation19]. Several earlier studies did not show a link of DHEA/S with cognition [Citation20,Citation21], but others did [Citation22–25]. The available evidence does not currently support a clear role of DHEA/S in improving or maintaining memory and other cognitive domains in healthy older individuals, but it might be useful in older persons with MCI or in the context of a hormonal deficiency [Citation26].

High levels of Cor are associated with poorer memory and it seems to be associated with hippocampal function [Citation27,Citation28]. However, it has also been shown that the decline in cognition with aging was not paralleled by changes in Cor levels [Citation29].

Somatotrophic hormones such as growth hormone (GH) and insulin-like growth factor-1 (IGF-1) may play an important role in brain function [Citation30]. GH and IGF-1 decline with age and the declines are associated with poorer cognitive functions [Citation31,Citation32]. The link between lower levels of IGF-1 and poorer cognitive function was derived from both cross-sectional and intervention studies with GHRH therapy [Citation33–35]. Whether endogenous levels of somatotrophic hormones have any modulating effects on cognition remains unclear.

Clear evidence does exist on the role of thyroid hormones in adult brain function [Citation36,Citation37]. Evidence of the association of thyroid hormones with cognition was derived from studies of patients with either hypothyroidism or hyperthyroidism [Citation38,Citation39].

Subjects, materials and methods

Subjects

This study was approved by the Institutional Review Board of the National University Hospital of Singapore and each volunteer gave his written informed consent. The method was previously reported [Citation7,Citation8]. Four hundred and seventy-two Singaporean Chinese men, aged between 29 and 72 y, were included in the analyses. As the primary objective of the study was to evaluate the determinants of the natural aging process, only men without a history of medical illnesses such as cancer, hypertension, thyroid dysfunction, diabetes, osteoporotic fracture, cardiovascular events, major sleep disorders, major joint surgery or bone fracture were included in the study. Subjects were not paid for their participation. The cohort of men represented the diverse spectrum of Chinese in Singapore, ranging from those with low to high levels of education, working and non-working men (retirees) and those in various types of vocation [Citation7]. Their profiles were typical of Singapore, which is a highly urbanized city-state with no rural population. Each subject answered a self-administered and investigator-guided questionnaire. Questions asked covered their medical, dietary, social, sex, exercise regime and family histories and other relevant histories regarding consumption of hormones, supplements and medication, types of beverages, smoking and alcohol consumption. They were not on any medication which might confound the cognitive functions being evaluated.

Methodologies

To improve our understanding of the associations between hormones, aging and cognition, we have concurrently measured hormone levels, lifestyle factors and cognitive function in healthy men. This has enabled the evaluation of the individual hormones’ association with cognition with adjustment for various confounding factors.

Cognitive function tests

The Swedish Performance Evaluation System (SPES) was developed over the last 40 years [Citation40]. Two tests from the SPES, the Symbol Digit for perceptual capacity and Digit Span for short-term memory were used in the study.

Symbol Digit

The Symbol Digit is a test of perceptual capacity which includes matching, memory and the speed of processing. In one row, a key to this coding task is given by the pairing of symbols with randomly arranged digits, 1–9. The task is to key in as fast as possible the digits corresponding to the symbols presented in random order in a second row. Each set consists of nine pairs of randomly arranged symbols and digits, and a total of 10 sets are presented. Performance is evaluated as the mean reaction time (msec) (RT) and the number of errors (Err) for the last 54 pairs of the test. Symbol Digit tests the individual’s ability to interpret and correctly match what he sees as well as the speed of his perceptual processing. It also involves hand–eye coordination. The two components of this test are RT and the number of errors (Err) [Citation40].

Digit Span

The Digit Span is a test of short-term memory capacity. In this test, a series of digits is presented on the screen. The digits are presented one at a time with a 1-s presentation time, and the task is to reproduce the series on the keyboard. Depending on the answer, the length of the following series is either increased or decreased. The test starts with a series of three digits and it is terminated after six incorrect answers. Performance is evaluated as the maximum string of numbers (DSpan) that the subject could remember successfully. A longer DSpan indicates a better short-term visual memory [Citation40].

The Symbol Digit and Digit Span are computer-based tests. All participants underwent a familiarization trial test before the actual scorings were recorded.

Exercise scores (MET-min)

Exercise may interact with both hormone levels and cognition [Citation6,Citation8]. The type, duration and frequency/week of exercise for each participant were collated from data from the self-administered and investigator-guided questionnaire. The intensity of the physical exercise was scored using the Metabolic Equivalent of Task (MET) for each exercise type. The scoring took into account the duration of each exercise episode and the frequency of the exercise per week to derive an exercise score. In accordance with the guidelines for Americans [Citation41], the MET cut-off values were as follows: light intensity (<3 MET), moderate intensity (3–6 MET) and high intensity (>6 MET). The total exercise score per week was expressed as metabolic equivalent-min (MET-min). The manner of calculating this score has been reported earlier [Citation8,Citation42].

Measurements of hormones

Measurements for T, E2, DHEA/S, Cor and SHBG

A 12 h fasting blood sample was collected from each participant and serum was separated and stored at −80 °C. Serum testosterone (T) and estradiol (E2) concentrations were measured using reagents and methods recommended by the World Health Organization Matched Reagent Program [Citation43] with modification to the scintillation proximity methods established in-house [Citation44]. DHEA/S and sex hormone binding globulin (SHBG) and Cor were measured by established radioimmunoassay methods reported earlier [Citation45]. The intra- and inter-assay coefficients of variation were less than 10% over the effective concentration ranges for T, DHEA/S and Cor and less than 15% for E2 and SHBG.

Measurements for IGF-1, BP3, INS, TSH, T4, T3 and GLU

Serum concentrations of IGF-1 and insulin-like growth factor binding protein-3 (BP3) were measured using immunoradiometric assay kits (Diagnostic Systems Laboratories, Inc., Webster, TX) as reported earlier [Citation46,Citation47]. The CV for duplication was <10%. The ranges for inter-batch-assay CV were 3.6–4.5% for serum IGF-1 and 6–9% for serum BP3. Serum concentrations of insulin (INS), thyroid stimulating hormone (TSH), T4 and triiodothyronine (T3) were measured in-house using the Axsym platform from Abbott. Glucose levels were measured using the hexokinase method on the in-house Axsym platform.

Method of calculation of Bioavailable T (BioT)

BioT was calculated using the computer formula of Vermeulen, which is available on the ISSAM website (www.issam.ch). Total T was computed as ng/dL, and SHBG as nmol/L. Albumin level was assumed to be 44. Hence, BioT was expressed as ng/dL [Citation48].

Statistical analysis

Statistical analyses were performed using SPSS for windows version 21.0 (Armonk, NY). Multilinear regression with the stepwise method was used for the various hormonal factors with the three parameters of the two cognitive domains studied.

Results

shows the correlation between age and hormones from the gonadal, adrenal, somatotrophic (including GLU) and the thyroid axes as well as the three parameters of cognition studied. Independent of other hormones, age was associated with decline in DHEA/S, IGF-1, T4, T and BioT, but increase in GLU, SHBG, E2 and RT. As was reported earlier [Citation43], in this sample, the older Singaporean men were exercising more intensely than younger men (). Other hormones did not show any age-related changes ().

Table 1. Linear regression analyses of age with endocrine factors and cognitive functions using the stepwise method of analyses.

shows the linear regression analyses, using the stepwise method, of hormones from the gonadal, adrenal and somatotrophic axes, age and exercise score with the three cognitive parameters of Err, RT and DSpan. Glucose is an important factor in the somatotrophic axis and was included in the analyses. The circulating level of glucose was significantly associated with all three parameters of the two cognitive domains studied. High GLU was associated with higher error rate, longer RT of the perceptual capacity domain and shorter DSpan of the short-term memory domain (). The IGF-binding protein-3 (BP3), the other component of the somatotrophic axis, was significantly associated with the memory domain; higher BP3 was associated with longer DSpan (). As was reported in an earlier study, age was positively associated and MET-min was negatively associated with RT of the perceptual domain (). Two hormones from the adrenal axis, Cor and DHEA/S were significantly associated with cognitive functions. High Cor was associated with higher error rate (Err), while high DHEA/S was associated with shorter RT (). All other hormones from the adrenal, somatotrophic and gonadal axes were not significantly associated with the three parameters of the two cognitive domains ().

Table 2. Linear regression analyses separately of Err, RT and DSpan with various endocrine factors using the stepwise method of analysis.

Discussion

The role of the neuroendocrine system, and in particular, the role of hormones in cognition has been established mainly through models of endocrine dysfunction such as congenital adrenal hyperplasia, menopause syndrome, hypogonadism, diabetes and hormone replacement therapy [Citation9]. It is however, unclear to what degree, if any, age-related changes in endogenous hormone levels are associated with decline in cognition in aging men. The present cross-sectional study evaluated whether age-related differences in endogenous hormone levels are associated with cognitive functioning in healthy community living men.

Aging has varying effects on healthy individuals, with some people exhibiting extensive alteration in physiological functions including cognition but others little or none [Citation49–52]. As we have reported earlier, age and a lifestyle habit of physical exercise were significantly associated with the perceptual capacity [Citation6]. Hence, in the present study, all correlational analyses of hormone levels with cognitive functions were adjusted for age and exercise intensity. If this is not done, the relationships of individual endogenous hormone levels with cognition might be confounded.

The regression analyses showed that endogenous levels of GLU were significantly associated with all three parameters of the perceptual and short-term memory cognitive domains. Higher circulating levels of glucose were associated with poorer perceptual capacity, with higher error rate and longer retention time. At the same time, higher levels of glucose were associated with poorer short-term visual memory. In the present study, none of the participants was diabetic or on medication for diabetes and their glucose levels were not in the pathological range. Therefore, the negative correlation of the glucose levels with the three parameters of cognition suggests that circulating levels of glucose per se may have a modulating effect on short-term memory and perceptual capacity. This finding implies that tighter control of blood glucose levels in diabetics and healthy men may modulate a high GLU-associated decline in cognition and should be investigated in future studies.

It has been suggested that prenatal exposure to androgens strongly influences the cognitive pattern in adulthood [Citation53]. Androgens (either directly or through conversion to estrogens) may be associated with visuospatial cognitive ability. This may be observed in patients with androgen excess, as in cases of congenital adrenal hyperplasia [Citation54], and androgen insensitivity [Citation55]. However, the association of androgens with cognition in studies of cross-sex hormone therapy in transsexuals and hormone replacement in hypogonadal men were equivocal [Citation56,Citation57]. In addition, the relation between baseline endogenous circulating androgens and spatial ability remains unclear [Citation9]. We have shown that circulating levels of testosterone, BioT, SHBG and estrogen were not significantly associated with any of the three parameters of cognition, in line with observations of several earlier studies [Citation27,Citation58,Citation59] but in contrast to some other studies [Citation60,Citation61]. The observation that the age-associated decline in androgens and increase in estradiol were not associated with cognition implies that circulating endogenous levels of sex hormones may not have a direct effect on cognition in men. The results imply that none of the gonadal factors has a modulating effect on cognition.

Cor and DHEA/S have been shown to be associated with human cognition [Citation22,Citation26,Citation28]. Age was associated with a linear decrease in DHEA/S levels, but not with circulating levels of Cor. We have shown that higher Cor levels were associated with higher error rate, and higher levels of DHEA/S were associated with lower RT in the perceptual capacity domain. The results suggest that these two hormones from the adrenal gland may have a role in the perceptual capacity domain of human cognition. We have shown that after adjusting for age, exercise intensity and other hormone levels, DHEA/S in a group of normal men aged 29–72 y was independently and significantly associated with cognition. By contrast, the Massachusetts Male Aging Study did not show any significant association between endogenous levels of DHEA/S and working memory, speed/attention and spatial ability in older men [Citation27]. It has been suggested that a decline in DHEA/Cor ratio may underlie some of the cognitive decline associated with aging as DHEA/S can attenuate the deleterious effects of Cor [Citation62,Citation63]. However, this suggestion was not borne out in the present study. We did not show any significant association of DHEAS/Cor ratio with any of the three parameters of cognition evaluated.

While Cor shows a relative steady level of secretion throughout aging, DHEA/S synthesis peaks in young adulthood and declines with age and by up to 80% in old age [Citation8,Citation64]. It has been suggested that the effect of DHEA/S is mediated indirectly through conversion to androgen or estradiol [Citation65]. However, as shown in the present study, androgens and E2 in the same group of men were not significantly associated with the two cognitive domains. This observation may imply a direct role of DHEA/S per se in modulating the perceptual capacity. A direct role of DHEA/S in cognition is supported by our earlier observation that DHEA/S affects sexual motivation in men, whereas androgens and estrogens do not [Citation66].

Age-related decline in cognition and Alzheimer’s disease have been associated with high Cor levels in some studies [Citation28,Citation67,Citation68], but not in others [Citation29,Citation69]. The reasons may relate to artefacts due to the biological media in which Cor was measure and to the measures of cognitive functions used [Citation28,Citation29,Citation68–70]. In the present study, we noted a direct correlation of circulating Cor levels with the error rate in the perceptual capacity in healthy men. This observation is in contrast to that of Gaysina et al. [Citation27], who did not show a significant relationship of morning Cor to midlife cognition.

Somatotrophic hormones play an important role in brain function [Citation31]. Age-related decline in growth hormone (GH) and IGF-1 in men concurrent with decline in cognition have been well established [Citation31,Citation32,Citation71]. However, whether endogenous levels of somatotrophic hormones have modulating roles on real time cognitive functions in healthy men is less clear. As with circulating insulin, IGF-1 and the IGF/BP3 ratio were not significantly associated with any of the three parameters of cognition evaluated. However, endogenous circulating levels of BP3 were positively associated with short-term memory. These observations were in contrast to those of some earlier studies [Citation72]. The result implied that BP3 per se may have a direct role in modulating the short-term memory domain in human cognition.

Clear evidence exists on the role of thyroid hormones in adult brain function [Citation36,Citation37]. Studies of patients with hypothyroidism and hyperthyroidism have shown that thyroid hormones are associated with cognition [Citation38,Citation39]. However, in the present study none of the thyroid hormones was significantly associated with perceptual and short-term memory cognitive domains. This suggests that endogenous levels of T4, T3 and TSH may not have a modulating role in the short-term memory and perceptual capacity domains of human cognition in healthy men.

We have shown that circulating levels of GLU, DHEA/S, Cor and BP3 were significantly associated with at least one of the parameters of the perceptual and short-term memory domains of human cognition.

A limitation of this study is that it is a cross-sectional study; hence no causal effect is attributable to the observed associations. Only two cognitive domains, the perceptual and memory domains were studied, hence cross-comparisons with studies with other domains of cognitions could not be made. On the other hand, a positive contribution of the present study is the involvement of a relatively wide age range (29–72 y) of Asian men who were healthy with no history of any major illnesses that might mar the actual association of endocrine factors and age with cognition. In addition, a range of lifestyle factors was able to be controlled for.

The findings suggest three conclusions and/or hypotheses for further investigation:

  1. A role for tighter control of blood glucose levels in cognitive decline with aging in men.

  2. Different hormones may be related to different parameters of cognition and “cognition” (thus cognitive decline) is not a unitary phenomenon.

  3. The potential for exogenous DHEA/S to slow cognitive decline in aging, especially as it relates to reaction time.

Acknowledgements

We would like to acknowledge the technical assistance from staff of the Endocrine Research and Service Laboratory of the Department of Obstetrics and Gynaecology, National University of Singapore, Singapore. This study was designed, conducted and data collected while Prof. Victor H. H. Goh was at the Department of Obstetrics and Gynaecology, National University of Singapore, Singapore. Prof. William Hart was intimately involved in the interpretation, drafting of the article and critical revision of the article for submission.

Declaration of interest

The authors report no declaration of interest. This study was supported, in part, by funds from the Academic Research Fund of the National University of Singapore, Singapore.

References

  • Leifke E, Gorenoi V, Wichers C, et al. Age-related changes of serum sex hormones, insulin-like growth fator-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol 2000;53:689–95
  • Harman SM, Metter EJ, Tobin JD, et al. Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001;86:724–31
  • Morley JE, Kaiser F, Raum WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the health human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulphate, and the ratio of insulin-like growth factor I to growth hormone. Proc Natl Acad Sci USA 1997;94:7537–42
  • Hanninen T, Koivisto K, Reinikainen KJ, et al. Prevalence of ageing-associated cognitive decline in an elderly population. Age Ageing 1996;25:201–5
  • Busse A, Bischkopf J, Riedel-Hellar SG, Angermeyer MC. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003;182:449–54
  • Goh VHH, Hart WG. The association of metabolic syndrome and aging with cognition in Asian men. Aging Male 2014;17:216–22
  • Goh VHH, Tong TYY, Mok HPP, Said B. Interactions among age, adiposity, bodyweight, lifestyle factors and sex steroid hormones in healthy Singaporean Chinese men. Asian J Androl 2007;9:611–21
  • Goh Victor HH, Tong Terry YY. The moderating impact of lifestyle factors on sex steroids, sexual activities and aging in Asian men. Asian J Androl 2011;13:596–604
  • Erlanger DM, Kutner KC, Jacobs AR. Hormone and cognition: current concepts and issues in neuropsychology. Review article. Neuropsychol Rev 1999;9:175–207
  • Nyberg F, Hallberg M. Growth hormone and cognitive function. Nat Rev Endocrinol 2013;9:357–65
  • Lamberts SWJ. The endocrinology of aging and the brain. JAMA Neurol 2002;59:1709–11
  • Moffat SD, Zonderman AB, Metter EJ, et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002;87:5001–7
  • Cherrier MM, Matsumoto AM, Amory JK, et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 2005;64:2063–8
  • Tan RS, Pu SJ. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s disease. Aging Male 2003;6:13–17
  • Yaffe K, Lui L-Y, Zmuda J, Cauley J. Sex hormones and cognitive function in older men. J Am Geriat Soc 2002;50:707–12
  • Fonda SJ, Bertrand R, O’Donnell A, et al. Age, hormones and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol Series A, Bio Sci Med Sci 2005;60:385–90
  • Sih R, Morley JE, Kaiser FE, et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661–7
  • Lu PH, Masterman DA, Mulnard R, et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 2006;63:177–85
  • Yen SS. Dehydroepiandrosterone sulfate and longevity: new clues for an old friend. Proc Natl Acad Sci USA 2001;98:8167–9
  • Wolf OT, Koster B, Bierings HG, et al. A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol Psychiatry 1997;42:845–8
  • Wolf OT, Neumann O, Hellhammer DH, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363–7
  • Hildreth KL, Gozansky WS, Jankowski CM, et al. Association of serum dehydroepiandrosterone sulphate and cognition in older adults: sex steroid, inflammatory, and metabolic mechanisms. Neuropsychology 2013;27:356–63
  • Valenti G, Ferrucci L, Lauretani F, et al. Dehydroepiandrosterone sulphate and cognitive function in the elderly: the In CHIANTI study. J Endocrinol Invest 2009;32:766–72
  • Haren MT, Banks WA, Perry III HM, et al. Predictors of serum testosterone and DHEAS in African-American men. Intl J Androl 2008;31:50–9
  • Sanders JL, Cappola AR, Arnold AM, et al. Concurrent change in dehydroepiandrosterone sulphate and functional performance in the oldest old: results from the Cardiovascular Health Study All Stars study. J Genrotol A Bio Sci Med Sci 2010;65:976–81
  • Maggio M, De Vita F, Fisichella A, et al. DHEA and cognitive function in the elderly. J Steroid Biochem Mol Biol 2015;145:281–92
  • Gaysina D, Gardner MP, Richards M, Ben-Shlomo Y. Cortisol and cognitive function in midlife: the role of childhood cognition and educational attainment. Psychoneuroendocrinol 2014;47:189–98
  • Beluche I, Carriere I, Ritchie K, Ancelin M. A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 2010;40:1039–49
  • Singh-Manoux A, Dugravot A, Elbaz A, et al. No evidence of a longitudinal association between diurnal cortisol patterns and cognition. Neurobiol Aging 2014;35:2239–45
  • Thornton PL, Ingram RL, Sonntag WE. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J Gerontol A Biol Sci Med Sci 2000;55:B106–12
  • Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Aging Res Rev 2005;4:195–212
  • Bellar D, Glickman EL, Juvancic-Heltzel J, Gunstad J. Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of health, fit older adults. Neuroscience 2011;178:133–7
  • Aleman A, Torres-Aleman I. Circulating insulin-like growth factor 1 and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol 2009;89:256–65
  • Saunders NL, Summers MJ. Attention and working memory deficits in mild cognitive impairment. J Clin Exp Neuropsychol 2010;32:350–7
  • Stanley TL, Chen CY, Branch KL, et al. Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab 2011;96:150–8
  • Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid–brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 2008;20:1101–14
  • Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007;32:49–65
  • Schrami FV, Goslar PW, Baxter L, Beason-Held LL. Thyroid stimulating hormone and cognition during severe, transient hypothyroidism. Neuro Endocrinol Lett 2011;32:279–85
  • Miller KJ, Parsons TD, Whybrow PC, et al. Verbal memory retrieval deficits associated with untreated hypothyroidism. J Neuropsychiatry Clin Neurosci 2007;19:132–6
  • Iregren A, Gamberale F, Kjellberg A. SPES: a psychological test system to diagnose environmental hazards. Neurotoxicol Terotol 1996;18:485–91
  • 2008 Physical activity guidelines for Americans. Washington (DC): US Department of Health and Human Services; 2008. Available from: http://www.health.gov/paguidelines/pdf/paguide.pdf. [last accessed 20 Apr 2014]
  • Goh VHH, Hart WG. Associations of physical exercise as a lifestyle habit with lean and fat body mass and handgrip strength and age in Asian men. Aging Male 2014;17:131–5
  • Sufi S, Donalson A, Jeffcoate SL. Method Manual. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Programme for the provision of matched assay reagents for the radioimmunoassay of hormones in reproductive physiology. Geneva: World Health Organization; 1992
  • Goh HH, Chow A, Wang FL, Ratnam SS. Comparisons of a tritium labelled-based classical radioimmunoassay with a newly developed scintillation proximity assay for measurement of plasma oestradiol-17-beta. J Med Lab Sci 1990;4:33–5
  • Chia SE, Goh VHH, Ong CN. Endocrine profiles of male workers with exposure to trichloroethylene. Am J Ind Med 1997;32:217–22
  • Probst-Hensch NM, Wang H, Goh VHH, et al. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women cancer. Epidemiol Biomarkers Prevention 2003;12:739–46
  • Goh VHH, Mu SC, Gao FK, Lim KS. Changes in body composition and endocrine and metabolic functions in healthy elderly Chinese men following growth hormone therapy. Aging Male (US) 1998;1:264–9
  • Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72
  • Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987;237:143–6
  • Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States black and nonblack population above 65 from 1982 to 1999. Proc Natl Acad Sci USA 2001;98:6354–9
  • Park DC, Lautenschlager G, Hedden T, et al. Models of visuospatial and verbal memory across the adult life span. Psychol Aging 2002;17:299–320
  • Sliwinski M, Buschke H. Cross-sectional and longitudinal relationships among age, cognition, and processing speed. Psychol Aging 1999;14:18–33
  • Kimura D. Sex hormones influence human cognitive pattern. Neuroendocrinol Lett 2002;23:67–77
  • Hampson E, Rovet JF, Altmann D. Spatial reasoning in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Develop Neuropsychol 1998;14:299–320
  • Imperato-McGinley J, Pichardo M, Gautier T, et al. Cognitive abilities in androgen-insensitive subjects: comparison with control males and females from the same kindred. Clin Endocrinol 1991;34:341–7
  • Slabbekoorn D, van Goozen SHM, Megens J, et al. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long term hormone effects in transsexuals. Psychoneuroendocrinol 1999;24:423–47
  • Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. A review. Eur J Endocrinol 2006;155:773–81
  • Ulubaev A, Lee DM, Purandare N, et al. Activational effects of sex hormones on cognition in men. Clin Endocrinol 2009;71:607–23
  • Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas 2011;69:322–37
  • Martin DM, Wittert G, Burns NR, et al. Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas 2007;57:182–94
  • Muller M, Aleman A, Grobbee DE, et al. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology 2005;64:866–71
  • Van Niekerk JK, Huppert FA, Herbert J. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinol 2001;26:591–612
  • Karishma KK, Hertber J. Dehydroepiandrosterone stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons, and prevents corticosterone-induced suppression. Eur J Neurosci 2002;16:445–53
  • Orentreich N, Brind JL, Vogelman JH, et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992;75:1002–4
  • Labrie F. DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 2010;182:97–148
  • Goh VHH, Tong TYY. Sleep, sex steroid hormones, sexual activities, and aging in Asian men. J Androl 2010;31:131–7
  • Rothman SM, Mattson MP. Adverse stress, hippocampal networks, and Alzheimer’s disease. Neuromolecular Med 2010;12:56–70
  • Karlamangla AS, Singer BH, Chodosh J, et al. Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging 2005;26:80–4
  • Comijs HC, Gerritsen L, Penninx BW, et al. The association between serum cortisol and cognitive decline in older person. Am J Geriatr Psychiat 2010;18:42–50
  • Ben-Shlomo Y, Gardner M, Lightman S. A life course approach to neuroendocrine systems: the example of the HPA axis. In: Kuh D, Cooper R, Hardy R, et al., eds. A life course approach to healthy ageing. Oxford: Oxford University Press; 2014;133–45
  • Deijen JB, Arwert LI, Drent ML. The GH/IGF-1 axis and cognitive changes across a 4-year period in healthy adults. ISRN Endocrinol 2011;2011:249421
  • Baker LD, Barsness SM, Borson S, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults. Arch Neurol 2012;69:1420–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.